Statins: putting the benefit/risk into perspective.
Shepherd
James
J
Institute of Biochemistry, Royal Infirmary, Glasgow, G4 0SF, UK.
D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D012206:Rhabdomyolysis / Q000139:chemically induced; D018570:Risk Assessment
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors